Fifth Third Bancorp
GENE

Fifth Third Bancorp’s Genetic Technologies Ltd. GENE Stock Holding History

Fifth Third Bancorp’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5
Closed – – 2381
2019
Q2 		$0 Hold
5
– – ﹤0.01% 2380
2019
Q1 		$0 Hold
5
– – ﹤0.01% 2335
2018
Q4 		$0 Hold
5
– – ﹤0.01% 2367
2018
Q3 		$0 Hold
5
– – ﹤0.01% 2349
2018
Q2 		$0 Buy
+5
New +$118 ﹤0.01% 2395

Other funds holding GENE

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Fifth Third Bancorp's GENE Position: Q3 2019 in Review

Fifth Third Bancorp sold out of Genetic Technologies Ltd. (GENE) in Q3 2019, closing a stake of 5 shares.

Fifth Third Bancorp first reported a position in GENE in Q2 2018 and held it in 5 quarters. The position peaked at $0 in Q2 2019. 6 funds tracked by Wall St. Rank hold GENE as of Q3 2019.

  • Fifth Third Bancorp reported no remaining Genetic Technologies Ltd. position as of Q3 2019 after selling out during the quarter.
  • Fifth Third Bancorp sold 5 Genetic Technologies Ltd. shares in Q3 2019.
  • Fifth Third Bancorp first reported a position in Genetic Technologies Ltd. in Q2 2018 and held it in 5 quarters.
  • Fifth Third Bancorp's Genetic Technologies Ltd. position peaked at $0 in Q2 2019.
  • 6 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q3 2019.

Based on Fifth Third Bancorp's 13F filing for Q3 2019, filed 14 Nov 2019.